// App-Quantinova.ai

POS1555-HPR (2022) : EVALUATION OF CONVERSATIONS IN MOTION: A PROGRAM DESIGNED TO IMPROVE PATIENT-PROVIDER COMMUNICATION IN THE CARE OF RHEUMATOID ARTHRITIS

Researchers

Presenter

  • E. Nikiphorou

Principal Investigators

  • S. Ploquin

  • M. Augustyniak

  • A. Negoescu

  • D. Walker

  • F. Haq

  • P. Lazure

  • S. Murray

Medical Centers

  • King’s College London, Centre for Rheumatic Disease, London, United Kingdom

  • AXDEV Group Inc., Performance Improvement Division, Brossard, Canada

  • Addenbrooke’s Hospital, Cambridge University Hospitals NHS Trust, Rheumatology Department, Cambridge, United Kingdom

  • Northumbria Healthcare NHS Foundation Trust, Rheumatology Department, Northumbria, United Kingdom

  • Eli Lilly and Company, Global Medical Education, Toronto, Canada

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Pfizer and Eli Lilly and Company

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved